Screener
Merck & Co.
MRKMerck & Co., Inc. is a global healthcare company focused on the discovery, development, and manufacturing of innovative health solutions.
Earnings
Next report
Oct 29, 2026 (in 2 months)Revenue estimate$17.3B
EPS estimate$2.22
Valuation & ratios
Competitors
By market cap
By revenue growth
By net margin
Profile
Merck & Co., Inc. is a global healthcare company focused on the discovery, development, and manufacturing of innovative health solutions. The company delivers a diverse portfolio of prescription medicines, biologic therapies, vaccines, and animal health products to address unmet medical needs. Its core value proposition centers on research-driven innovation to treat human disorders and manage the health of livestock and companion animals.
Competitive position
A leading global research-based biopharmaceutical company with a dominant position in oncology and vaccines, supported by a significant animal health business.
GeographiesUnited States, European Union, Japan, China, Emerging Markets
Customer segmentsHealthcare Providers, Government Entities, Veterinary Clinics, Agricultural Producers
Business modelResearch and Development, Manufacturing, B2B Distribution, Licensing and Alliances
SuppliersRaw material suppliers, Intermediate chemical manufacturers, Academic research institutions, Third-party manufacturing partners
CustomersDrug wholesalers (e.g., McKesson, AmerisourceBergen), Pharmacy benefit managers, Public health systems, Retail pharmacies, Veterinary distributors
CountryUnited States of America
Listed1949
CEORobert Davis
SectorHealthcare
IndustryDrug Manufacturers - General
Websitemerck.com
FilingsSEC EDGAR
FAQ
- What is Merck & Co.'s market cap?
- Merck & Co. (MRK) has a market capitalization of $377.72B and trades on NYSE.
- What is Merck & Co.'s revenue and profitability?
- Merck & Co. generated $66.6B in trailing twelve-month revenue with net income of $3.2B, representing a net margin of 4.8%. Gross margin stands at 73.0%, with free cash flow of $16.1B. These figures are based on the Q2 2026 filing.
- Who are Merck & Co.'s competitors?
- Merck & Co.'s key competitors include Bristol-Myers Squibb, Zoetis Inc., Johnson & Johnson, and others. These companies compete in similar markets and product categories.
- Who does Merck & Co. partner with?
- Merck & Co.'s notable partners include AstraZeneca, Eisai Co., Ltd., Pfizer Inc., and others.
- What subsidiaries does Merck & Co. have?
- Merck & Co.'s subsidiaries include Cidara Therapeutics, Inc., Allflex Livestock Intelligence, Sure Petcare.
- Where is Merck & Co. headquartered?
- Merck & Co. is headquartered in United States of America. It has been publicly traded since 1949.
